Analyst consensus rating
Cocrystal Pharma Analyst Rating: Strong Buy
Direct answer
Cocrystal Pharma's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $8.00.
Forecast evidence checked October 18, 2026.
Get free Cocrystal Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.02
- Average price target
- $8.00
- High price target
- $10.00
- Low price target
- $6.00
- Low target gap
- +488.2%
- Target upside
- +684.3%
- High target gap
- +880.4%
- Target range width
- 392.2%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- October 18, 2026
- Valid through
- October 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Cocrystal Pharma?
Cocrystal Pharma has a verified Strong Buy consensus. The same dataset has an average price target of $8.00.
How far are Cocrystal Pharma's low and high targets from the recorded price?
The low target implies +488.2%, while the high target implies +880.4%.
How many analysts are included in Cocrystal Pharma's consensus?
The verified consensus includes 3 analysts.
How is Cocrystal Pharma's target upside or downside calculated?
The average target of $8.00 is divided by the recorded price of $1.02, then one is subtracted to produce +684.3%. This does not guarantee a future return.
When was Cocrystal Pharma's analyst forecast verified?
The data was verified on 2026-10-18. The dataset is valid through 2026-10-25.